Short-Term Safety and Efficacy of a Single Intravitreal Bevacizumab Injection for the Management of Polypoidal Choroidal Vasculopathy

Publisher： Karger

E-ISSN： 1423-0267|223|2|85-92

ISSN： 0030-3755

Source： Ophthalmologica, Vol.223, Iss.2, 2008-11, pp. : 85-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Therapeutic Effects of Intravitreal Bevacizumab in a Patient with Recalcitrant Idiopathic Polypoidal Choroidal Vasculopathy

By Ghajarnia Mehdi   Kurup Shree   Eller Andrew  

Seminars in Ophthalmology, Vol. 22, Iss. 2, 2007-04 ,pp. : 127-131

Informa Healthcare

Access to resources Recommend Favorite

Photodynamic Therapy Combined with Intravitreal Injection of Vascular Endothelial Growth Factor Antibody for Polypoidal Choroidal Vasculopathy

By  

Ophthalmologica, Vol. 225, Iss. 3, 2011-01 ,pp. : 169-175

Karger

Access to resources Recommend Favorite

Long-Term Follow-Up of Polypoidal Choroidal Vasculopathy Secondary to Angioid Streaks Treated by Intravitreal Aflibercept and Ranibizumab

By  

Case Reports in Ophthalmology, Vol. 8, Iss. 1, 2017-04 ,pp. : 221-231

Karger

Access to resources Recommend Favorite

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy

By  

Case Reports in Ophthalmology, Vol. 6, Iss. 3, 2015-12 ,pp. : 477-481

Karger

Access to resources Recommend Favorite

Two-Year Results of Photodynamic Therapy Combined with Intravitreal Anti-Vascular Endothelial Growth Factor for Polypoidal Choroidal Vasculopathy

By  

Ophthalmologica, Vol. 226, Iss. 4, 2011-09 ,pp. : 205-213

Karger

Access to resources Recommend Favorite